MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$826M
RSV
$193M
COVID19
$453M
Provision for (benefit
from) tax provision
$27M
Loss before income
taxes
-$799M
Interest income
$70M
Product And Service
Other
$33M
Product Sales
$645M
Other expense, net
-$12M
Loss from operations
-$857M
Total revenue
$678M
Total operating
expenses
$1,535M
Selling, general and
administrative
$308M
Research and development
$775M
Cost of sales
$452M
Back
Back
Income Statement
source: myfinsight.com
Master Final R&D Day 2021 Slides (09
Moderna, Inc. (MRNA)
Master Final R&D Day 2021 Slides (09
Moderna, Inc. (MRNA)